Chairman of China's Simcere Pharma Offers Buyout

11.03.2013 - China-based Simcere Pharmaceutical Group received a buyout offer from a consortium led by founder-chairman Jinsheng Ren for $9.56 per American depositary share (ADS), valuing the...